The latest updates and insights for health researchers. We share stories from our research partners, best practices, and product updates. Subscribe to the Pattern Pulse newsletter here.
Clinical trial sponsors are constantly seeking ways to accelerate study timelines, thereby more rapidly delivering therapeutics to patients and optimizing return on R&D investment. Accelerating clinical trials means acquiring high-quality data faster. It means developing protocols, configuring technology, activating research...
The ICAN-NC study is evaluating the efficacy of remote therapy sessions and a supplemental app for breast cancer patients in rural areas. The digital health intervention, powered by Pattern, provides participants with symptom tracking and cognitive behavioral coping tools to help reduce pain, fatigue, and distress.
Biometric data is a powerful addition to a study protocol, offering a variety of data about participants’ activity levels and well-being. Pattern has deep experience working with study teams to select the best-fit devices for their studies and integrating…
As the year comes to a close, the Pattern Health team has taken some time to reflect. We are honored to support you, our amazing partners, who are pushing the boundaries of research and developing life-changing therapeutics. This holiday season,...
Pattern’s latest release enables a more streamlined experience for participants, providers, and research teams. The new functionality accommodates all varieties of virtual interactions, from remote eConsent visits to medical appointments.
IWQOL-Lite-CT© (Impact of Weight on Quality of Life-Lite-Clinical Trials) is the gold standard patient-reported outcome (PRO) measure of weight-related quality of life in adults designed for use in clinical trials. As the exclusive licensor of IWQOL-Lite-CT©, Pattern Health works with CROs and biopharma organizations to implement the measure for regulated clinical trials.
With the expanding market of biometric devices, selecting the right tools for research studies can be challenging. In this article, we provide guidance to healthcare researchers on selecting biometric devices, considering factors such as cost, provisioning process, battery life, user experience, device family, accuracy, and reliability.
The Duke EMPOWER study team partnered with Pattern to help patients with Interstitial Lung Disease discover relevant clinical trials, access information and exercise plans, track biometrics, and more!
The U.S. Food and Drug Administration (FDA) recently released its long-awaited draft guidance supporting the use of decentralized clinical trials (DCTs) for drugs, biologics, and devices. The new guidance clarifies the FDA's position on DCTs, inspiring confidence in their use...
Durham, NC, Nov 30, 2022 – Pattern Health today announced the latest addition to its digital health Exchange, Surgical Risk Prediction Suite (SRPS). SRPS is a clinical decision support tool authored by Duke Health that helps health systems anticipate and...
The Duke Clinical Research Institute study was the first to incorporate mobile health technology to follow heart failure patients long-term. The study showed that using patients’ biometric information and medication adherence data can help customize guideline-based recommendations to improve self-care....
Durham, NC, Sep 22, 2022 – Pattern Health, a digital health company, today announced the closing of a $3.3 million series A funding round. The round was led by the Dr. William H. Joyce Family Office, with contributions from existing...